Silver Book Fact

People with persistent pain who used complementary and alternative medicine (CAM) had lower average health care expenditures than nonusers ($3,797 versus $4,153).

Lind B, Lafferty W, Tyree P, Diehr P. Comparison of Health Care Expenditures Among Insured Users and Nonusers of Complementary and Alternative Medicine in Washington State: A cost minimization analysis. J Altern Complement Med. 2010; 16(4): 411-17. http://online.liebertpub.com/doi/abs/10.1089/acm.2009.0261

Reference

Title
Comparison of Health Care Expenditures Among Insured Users and Nonusers of Complementary and Alternative Medicine in Washington State: A cost minimization analysis
Publication
J Altern Complement Med
Publication Date
2010
Authors
Lind B, Lafferty W, Tyree P, Diehr P
Volume & Issue
Volume 16, Issue 4
Pages
411-17
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • A proteasome inhibitor was found to reduce pain and joint destruction in an animal model of osteoarthritis, suggesting that nontoxic proteasome inhibitors could offer a novel pharmacotherapy option.  
  • Resolvins, a family of lipid mediators, have shown potential in resolving persistent inflammatory pain.  
  • In individuals with persistent low back pain, tanezumab, a humanized anti-nerve growth factor antibody, showed clinical and statistical analgesic efficacy that was superior to placebo and naproxen.  
  • Advances in neuroimaging will continue to offer information on the brain’s functioning and how it correlates to the pain experience.  
  • Growth hormone treatment in patients with fibromyalgia is effective in reducing pain with sustained action over time.